Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
RBB Bancorp
RBB
$451M
| $825K | ﹤0.01% |
35,842
| – | – |
|
3227
Rubrik
RBRK
$15.4B
| $824K | ﹤0.01% |
25,620
+860
| +3% | +$28.5K |
|
3228
NB Bancorp
NBBK
$1.02B
| $822K | ﹤0.01% |
+44,300
| New | +$783K |
|
|
EFT
3229
Eaton Vance Floating-Rate Income Trust
EFT
$284M
| $822K | ﹤0.01% |
63,831
+13,009
| +26% | +$172K |
|
3230
iRadimed
IRMD
$1.17B
| $821K | ﹤0.01% |
16,333
+6,615
| +68% | +$305K |
|
3231
Alector
ALEC
$168M
| $821K | ﹤0.01% |
176,209
+73,103
| +71% | +$392K |
|
3232
iShares MSCI Australia ETF
EWA
$1.44B
| $819K | ﹤0.01% |
30,222
+15,041
| +99% | +$380K |
|
3233
Wayfair
W
$11.8B
| $819K | ﹤0.01% |
14,583
-51,661
| -78% | -$2.49M |
|
3234
Barings BDC
BBDC
$881M
| $818K | ﹤0.01% |
83,518
-1,431
| -2% | -$14.2K |
|
3235
Nu Skin
NUS
$251M
| $816K | ﹤0.01% |
110,763
-134,017
| -55% | -$1.25M |
|
|
NXC
3236
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
| $807K | ﹤0.01% |
57,086
-1,062
| -2% | -$14.5K |
|
3237
InterContinental Hotels
IHG
$23.5B
| $807K | ﹤0.01% |
7,275
+373
| +5% | +$38.2K |
|
3238
Utah Medical Products
UTMD
$232M
| $807K | ﹤0.01% |
12,054
+7,450
| +162% | +$506K |
|
3239
BlackRock Enhanced Global Dividend Trust
BOE
$676M
| $806K | ﹤0.01% |
71,605
+3,498
| +5% | +$38.1K |
|
3240
Nuveen Mortgage and Income Fund
JLS
$94.2M
| $806K | ﹤0.01% |
43,729
-4,426
| -9% | -$80.2K |
|
|
DHC
3241
Diversified Healthcare Trust
DHC
$2.13B
| $805K | ﹤0.01% |
+192,115
| New | +$647K |
|
3242
Blend Labs
BLND
$467M
| $800K | ﹤0.01% |
+213,319
| New | +$707K |
|
3243
iShares MSCI BIC ETF
BKF
$78.6M
| $799K | ﹤0.01% |
19,751
+152
| +0.8% | +$5.54K |
|
3244
Douglas Dynamics
PLOW
$972M
| $798K | ﹤0.01% |
28,940
+12,930
| +81% | +$341K |
|
|
DHIL
3245
DELISTED
Diamond Hill
DHIL
| $798K | ﹤0.01% |
4,935
| – | – |
|
3246
JELD-WEN Holding
JELD
$156M
| $796K | ﹤0.01% |
50,324
-52,092
| -51% | -$765K |
|
3247
Pacer Trendpilot 100 ETF
PTNQ
$1.26B
| $791K | ﹤0.01% |
+10,791
| New | +$774K |
|
|
EVF
3248
Eaton Vance Senior Income Trust
EVF
$90.3M
| $782K | ﹤0.01% |
126,485
+6,120
| +5% | +$38.3K |
|
3249
Aura Biosciences
AURA
$728M
| $780K | ﹤0.01% |
+87,592
| New | +$751K |
|
|
BSJO
3250
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
| $776K | ﹤0.01% |
34,152
-10,698
| -24% | -$243K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.